Picture of Abionyx Pharma SA logo

ABNX — Abionyx Pharma SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapSucker Stock

Brief: Bpifrance Acknowledges Technical Failure Of Cerenis ISI Project "Apotheosis"

May 2 (Reuters) - CERENIS THERAPEUTICS HOLDING SA
 CEREN.PA :
    * CERENIS THERAPEUTICS: ACKNOWLEDGEMENT BY BPIFRANCE OF THE
TECHNICAL FAILURE OF THE ISI PROJECT "APOTHEOSIS" WHICH FUNDED
IMAGING STUDIES WITH CER-001
    * COMPANY WAS NOTIFIED OF DEBT EXEMPTION FOR TOTAL AMOUNT OF
4,602,943 EUROS, THUS TERMINATING PROJECT AND LEADING TO END OF
PAYMENTS ON THIS PROJECT
    * THIS DECISION WILL GENERATE REVENUE OF 4,602,943 EUROS
OVER
FIRST HALF OF 2019

Source text for Eikon:  ID:nBw6NQSd3a 
Further company coverage:  CEREN.PA 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Abionyx Pharma SA

See all news